Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Opinion Articles

Latest Opinion Articles

"" Photograph by Charly Kasereka
Opinion article
Opinion article |
07 December 2021
HIV/AIDS

Lancet HIV: COVID-19 antivirals must not affect HIV drug supply

2 min
MSF Nurse dispensing 3rd line ARTs to patient living with HIV. Photograph by Anshul Uniyal
Opinion article
Opinion article |
01 December 2021
HIV/AIDS

Why are people living with HIV still dying of AIDS in India?

4 min
Finda collects her six months of ART and related drugs at MSF-supported pharmacy as part of her months consultation at the MSF-supported HIV outpatient department at Matam health centre, Conakry, Guinea Photograph by Albert Masias
Opinion article
Opinion article |
01 December 2021
HIV/AIDS

This World AIDS Day: How to defeat cryptococcal meningitis, an outsider

11 min
At MSF’s post-operative care hospital in Mosul (Iraq), infection and prevention control (IPC) measures are implemented. One of the pillars of IPC consists in cleaning, sterilizing and sanitizing. Photograph by Mario Fawaz
Opinion article
Opinion article |
18 November 2021
Antimicrobial resistance

Lancet Microbe: Leaving no one behind: the need for a truly global response to antimicrobial resistance

A Médecins Sans Frontières nurse prepares a single dose of LAmB, an intravenous infusion administered over a short period of 2–3 hours. Photo by Matthew Smeal
Opinion article
Opinion article |
20 August 2021
Tropical & neglected diseases

BMJ Global Health: Control of visceral leishmaniasis in East Africa: fragile progress, new threats

3 min
MSF donated 3.5 tonnes of personal protective equipment to health workers at the Wuhan Jinyintan Hospital in Hubei province. Wuhan Jinyintan Hospital is one of the designated hospitals providing treatment to COVID-19 patients, especially those in severe and critical conditions Photo by MSF
Opinion article
Opinion article |
25 March 2020
COVID-19
Canada

Coronavirus vaccine must be affordable and accessible

6 min
The pneumonia vaccine from GSK used for vaccination in refugee camps in Greek islands was made available at a special reduced price of US$9 while its retail price is $168 in Greece. Photograph by Anna Pantelia
Opinion article
Opinion article |
29 January 2020
Vaccines
Global

A new shot at protecting children from pneumonia: will leaders accelerate access for the millions of children left behind?

5 min
So called “orange pills” (Amoxicillin), an antibiotic very popular among patients in Ahmed Shah Baba hospital in Kabul. Photograph by Doris Burtscher Photograph by Doris Burtscher
Opinion article
Opinion article |
21 November 2019
Antimicrobial resistance
India

World Antibiotic Awareness Week: Lack of access

7 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury